antagonist, propranolol, on testosterone production have been determined and the role of cyclic AMP has been investigated. The results obtained indicate that physiological amounts of catecholamines stimulate testosterone production via cyclic AMP in mouse Leydig cells and that this response 'develops' in the Leydig cells after 1 day in culture and is then maintained for approx. 2 days.
Adult mouse Leydig cells were isolated by mechanical dissociation of the testes followed by purification on a &90% Percoll gradient as described previously (Schumacher et al., 1978; Hunter et al., 1982) . The Leydig cells (100000 cells/well) were cultured in Dulbecco's modified Eagle's medium (1 ml) with Kanamycin (0.1 ng/ml) (Gibco) and 10% foetal-calf serum (Gibco). The medium was changed daily and the cells were stimulated on day 2 of culture with catecholamines or lutropin as indicated for 2h in the presence of isobutylmethylxanthine (0.2 mM), unless otherwise stated.
In a series of experiments carried out it was found that isoprenaline (10-0.1 PM) added to freshly prepared Leydig cells 2h after being plated out in the culture wells had little or no effect on testosterone production. However, addition of this catecholamine analogue on days 1, 2 and 3 of culture consistently stimulated testosterone production. The results from a representative experiment are shown in Fig. 1 . In this experiment two preparations of Leydig cells were made each from 10 mice killed either by cervical dislocation or by gassing with CO,. There were no detectable differences in the results obtained from these two preparations. In contrast with testosterone production, isoprenaline did stimulate cyclic AMP production on day 0 of culture, which increased on each subsequent day of culture. The capacity of the Leydig cells to respond to isoprenaline in the stimulation of testosterone production varied with different preparations from 20 to 90% of that obtained with lutropin. Further experiments were carried out to determine if inclusion of foetal-calf serum in the culture medium influenced the response to catecholamines. The results are given in Table 1 . In agreement with the results in Fig. 1 , little or no stimulation by isoprenaline of testosterone production was obtained on day 0 of culture in the presence of either foetal-calf serum or 1.5% (w/v) albumin. However, stimulation of cyclic AMP levels on day 0 was approx. three times higher in the cells cultured with foetal-calf serum compared with albumin. On subsequent days, stimulation by isoprenaline of both testosterone and cyclic AMP was obtained with albumin in the culture medium but much higher levels were attained in the presence of foetal-calf serum. Higher lutropin-stimulated testosterone but not cyclic-AMP levels were obtained in the presence of foetal-calf serum compared with albumin on all days of culture.
Dose-response experiments for isoprenaline showed that a small increase in testosterone production was obtained with 10nwisoprenaline and reached a maximum with approx. 1 PM. A parallel dose-response curve for isoprenaline-stimulated cyclic AMP production was obtained, the only difference being that a stimulation was not observed with IOnM. Isoprenaline stimulation of testosterone production was inhibited by the Day of culture pantagonist propranolol in a dose-dependent manner; detectable inhibition of the isoprenaline ( 1 0~~) effect was observed with 0.1 puM-propranolol and was completely inhibited with approx. 10-100p-propranolol. Similarly isoprenalinestimulated cyclic AMP production was inhibited by propranolol.
The effect of the phosphodiesterase inhibitor isobutylmethylxanthine on isoprenaline-stimulated testosterone and cyclic AMP production was investigated. It was clearly demonstrated that omission of this inhibitor almost completely prevented the detection of cyclic AMP and testosterone formation. The amounts of cyclic AMP detected even in the presence of isobutylmethylxanthine were very low (approx. 20 pmol/106 cells per 2h) compared with those obtained in the presence of lutropin (> 1000pmo1/106 cells per 2h).
A time-course study of cyclic AMP production during stimulation with isoprenaline ( 1 0~~) showed that this nucleotide increased continuously during 2 h incubation. The stimulation of testosterone production by isoprenaline and lutropin increased in parallel with time. No additional effect of isoprenaline on the lutropin stimulation of testosterone was seen both these stimulants were added together.
The effect of isoprenaline on testosterone and cyclic AMP production in the presence of different doses of lutropin was investigated. With submaximal amounts of lutropin, isoprenaline ( 1 0~~) had an additive effect on testosterone production. However, with maximum stimulating levels of lutropin, no further effect of isoprenaline was detectable. With amounts of lutropin less than l.Ong/ml no effects on cyclic AMP production could be detected and with isoprenaline ( 1 0~~) the cyclic AMP production was low and consistent with the effect of isoprenaline alone (22 f 5.3 pmol/106 cells). With l.Ong/ml and greater, no further effects of isoprenaline could be detected compared with the large effects of lutropin.
Adrenaline was found to stimulate testosterone production in a dosedependent manner. Its effect was not additive to lutropin when maximum stimulating levels of the latter were used. It may be concluded from our studies that purified mouse Leydig cells can be stimulated by catecholamides to form testosterone and that this response is detectable after 1 day in culture. Although foetal-calf serum enhanced the responses obtained, the cells still responded to isoprenaline when the cells were cultured in medium containing albumin. Previous studies by Eik-Nes (1969 , 1971 (1966) have shown that isoprenaline increases blood flow in the testicular artery of the ram. Although extensive studies have not been carried out in our work on the characterization of the catecholamine receptors, the effects were obtained with the P-agonists isoprenaline and adrenaline and blocked by the B-antagonist propranolol, thus indicating that preceptors are involved.
The reason for the development in response of testosterone production to isoprenaline is unclear. This may be a property of these cells when placed in culture. It is unlikely that it is due to another cell contaminant, because these would be less than 5% of the total cell population and would in any case be present on the first day of culture. In addition these cell contaminants would presumably be activating testosterone production via their cyclic AMP action on Leydig cells. However, 'exogenous' levels of cyclic AMP would have to be extremely high because of the poor uptake of this nucleotide by cells and it was demonstrated that isoprenaline-stimulated levels were very low compared with the response to lutropin. In addition, one of the possible contaminants of the Leydig cells, erythrocytes, were found to have no effect when added to the cell cultures. Another possible contaminant in the Leydig-cell preparations are Sertoli cells, although this is considered to be unlikely in view of the density-gradient-centrifugation procedure used to purify the Leydig cells. Sertoli cells have been reported to respond to Fadrenergic agonists (see below) and follitropin. However, it was found that various doses of the latter added on day 0 and day 1 had no detectable specific effect on cycljc AMP or testosterone production. It is also possible that p-adrenergic receptors are normally present in the mouse testis Leydig cells and that they are 'desensitized' because of the stress conditions of killing the animals and preparation of the cells. This would cause a loss of these receptors, which would have to be resynthesized before a response could be demonstrated. In order to investigate this possibility a less stressful method of killing the mice (CO, asphyxiation) was compared with the usual method (cervical dislocation), but no differences in the responses were obtained. This does not prove that desensitization is not taking place. However, the fact that isoprenaline increased cyclic AMP production on day 0 would also argue against this. The 'lesion' on day 0 would seem to be between cyclic AMP and formation of testosterone.
It has been demonstrated that another testis-cell type, the Sertoli cell, also responds to catecholamines to form both cyclic AMP (Verhoeven et al., 1981) ; Heindel et a[., 1981) and oestradiol-178 (Verhoeven et al., 1979) . The amounts required for maximum stimulation were in the order of 1 4 . 1 PM. Freshly isolated Sertoli cells do respond to catecholamines (Verhoeven, 1981) . However, Verhoeven et al. (1981) noted that isoprenaline-stimulated cyclic AMP and aromatase activity increased continuously during the 10 days of culture of these cells. It has also recently been demonstrated that the response to catecholamines develops in rat granulosa cells in culture from a 2-fold increase in cyclic AMP and progesterone production on day 0 to a 90-fold and 6-fold increase respectively after 2 days in culture (Kliachko & Zor, 1981) .
As noted above, the cyclic AMP levels achieved with maximum stimulating levels of isoprenaline were much lower than those obtained with lutropin. This implies that the number of padrenergic receptors are limited in the mouse Leydig cells compared with the lutropin receptors. That only low amounts of cyclic AMP are required to stimulate steroidogenesis is in accordance with previous studies (Catt & Dufau, 1973; Moyle & Ramachandran, 1973; Rommerts et al., 1973; Schumacher et al., 1979) . It is interesting to note that 0.1 ng of lutropin/ml was the minimum amount required to stimulate testosterone production and this corresponded with the maximum production obtained with isoprenaline. However, isoprenaline gave a 5-fold stimulation of cyclic AMP production, whereas there was no detectable increase in this nucleotide with 0.1 ng of lutropin/ml (3.8 k 3.2, compared with basal levels of 4.3 +0.6pmol/106 cells per 2h). This argues against a role of cyclic AMP with these amounts of lutropin although indirect measurements of cyclic AMP levels by protein kinase activation or by binding to the protein kinase regulatory subunit indicate that cyclic AMP is involved (Cooke & Van der Kemp, 1976; Dufau et al., 1977) .
Stimulation of both testosterone and cyclic AMP by isoprenaline was found to be highly dependent on the presence of the phosphodiesterase inhibitor isobutylmethylxanthine. These results strongly indicate that isoprenaline stimulates steroidogenesis via cyclic AMP. This conclusion is strengthened by the fact that the effects of isoprenaline on testosterone are not additive to the maximum stimulating levels of lutropin. An active phosphodiesterase is apparently present in the Leydig cells. A decrease in the activity of this enzyme during the first day of culture may partly explain the increases during this period in lutropin and isoprenaline-stimulated cyclic AMP production.
Further studies are required to elucidate the reasons for the development of the response of the Leydig cells to catecholamines in culture and to determine the possible physiological significance of P-adrenergic stimulation of testosterone regulation in uiuo.
The modulation of most cellular responses by hormones or neurotransmitter substances shows biphasic kinetics, characterized by an initial stimulation, followed by a decrease or attentuation in the response to the agonist (desensitization). Desensitization to hormonal stimulation of adenylate cyclase in various cell types has been considered to be related to changes occurring in at least one of the three major membrane proteins. In addition to the receptor and the adenylate cyclase unit, nucleotide-dependent regulatory protein(s) (N-protein; also known as G-protein) plays a critical role in transducing the information of hormone-receptor complex formation across the cell membrane to the catalytic unit (for review. see Rodbell. 1980) . No change in catalytic-unit activities has been found on direct stimulation of the enzyme. Therefore desensitization of cyclic AMP accumulation in response to P-adrenergic agonists has been attributed to changes occurring to the receptor, N-protein or both. In many systems there is initially a loss of efficacy, or coupling, of the receptor for the activation of adenylate cyclase followed by a loss of receptors for the agonist from the cell membrane.
Our work has aimed at studying the cause of the rapid. acute desensitization (occurring over minutes) of p-adrenergic stimulation of cyclic AMP accumulation in turkey erythrocytes, with the aim of assessing this as a model for hormone adenylate cyclase systems in general.
In turkey erythrocytes it appears there is no loss of P-adrenergic receptors, as judged by 13H1dihydroalprenolo1 binding, during 4-5h of exposure to isoprenaline (Pike & Lefkowitz, 1980a) . We therefore reasoned that desensitization of adenylate cyclase in avian erythrocytes may be associated with some change occurring to N-protein. Selinger and his coworkers (Cassel & Selinger, 1977; Cassel et al., 1979) have described a system in turkey erythrocyte membranes whereby catecholamines may not only activate, but also decrease, adenylate cyclase activities. Agonist-induced displacement of bound G D P from N-protein and replacement with GTP {or non-hydrolysable analogues, such as guanylimidodiphosphate and guanosine 5'-[ P,y-imidoltriphosphate (p[NH]ppG) activates not only adenylate cyclase but also an agonist-dependent GTPase.
The resultant production of GDP diminishes the activity of adenylate cyclase (Cassel & Selinger, 1977) . Until now it has not been clearly demonstrated that a major controlling influence of hormone desensitization in intact cells is some change of, or brought about by, N-protein.
We have used cell-fusion techniques (Schramm et al.. 1977; Schulster et al., 1978) to study the catecholamine responsiveness of intact turkey erythrocytes that have been acutely desensitized to isoprenaline and the restoration of the response by additional, hormonally unaltered, N-protein. The use of human erythrocytes (or their membranes) as donors for N-protein is advantageous in such studies since they possess few or no &receptors and adenylate cyclase activity (Kaslow et al., 1979; Nielson et al., 1980) . They seem to contain as much N-protein as other membrane preparations replete in hormonally-responsive adenylate cyclase components (Nielson et al., 1980) . Cholera-toxin treatment of human erythrocytes before fusion served to alter N-protein by ADP ribosylation (Kaslow et al., 1979) resulting in inhibition of GTPase activity. such that it was incapable of maintaining desensitization. N-protein thus 'activated' by cholera toxin and transferred to desensitized turkey erythrocytes, using cell-fusion techniques, was therefore examined for its ability to increase the rate of catecholamine-stimulated cyclic AMP accumulation.
